Remove Cardiothoracic Remove Heart Disease Remove Outcomes
article thumbnail

Almost 50% of Patients Under 60 Years Choose TAVR Over Surgical Aortic Valve Replacement with Worse Outcomes

DAIC

years after SAVR to assess their outcomes. Secondary outcomes included rates of reoperation, infective endocarditis, stroke, and hospital admissions for heart failure. By 2021 almost half of patients younger than 60 years were receiving TAVR rather than SAVR. The research team followed these patients for a median time of 2.4

article thumbnail

The Society of Thoracic Surgeons Launches New Valve Surgery Risk Calculators

DAIC

As cardiothoracic surgery continues to evolve, STS has responded by adding new risk models to guide treatment decisions and benchmark performance,” said STS President Jennifer C. The STS used recent national data from the STS Adult Cardiac Surgery Database between 2012 and 2023 to analyze outcomes of SAVR after previous TAVR.

TAVR 111
article thumbnail

El Camino Health Cardiologist Earns International Award for Achievements in Advancing Cardiovascular Field

DAIC

Goar, MD, medical director at the Norma Melchor Heart & Vascular Institute , was distinguished with the Andreas Grüntzig Ethica Award , the highest global honor in interventional cardiology. Improving patient care and outcomes is what drives my commitment to helping find new solutions in the field.

article thumbnail

STS Announces Late-breaker Research to Be Presented at the 2024 Annual Meeting

DAIC

The conference, healthcare’s leading scientific and educational convening specializing in cardiothoracic surgery, has a rich history of showcasing clinical trials with a strong foundation of detailed methodology and trusted data collection governed by ethical clinical principles.

Research 111
article thumbnail

Determinants of survival following heart transplantation in adults with congenital heart disease

Journal of Cardiothoracic Surgery

Adult patients surviving with congenital heart disease (ACHD) is growing. We examine the factors associated with heart transplant outcomes in this challenging population with complex anatomy requiring redo-sur.

article thumbnail

Henry Ford Health Heart Failure Patient First in Michigan to Receive Breakthrough Device

DAIC

Henry Ford Health's Center for Structural Heart Disease team delivered its first in Michigan FDA-approved VOQUE Transcatheter Tricuspid Valve Replacement System to a heart failure patient on February 13, 2024 at Henry Ford Hospital in Detroit. Medical Director of Structural Heart Disease at Henry Ford Health. “We

article thumbnail

The Nation’s Heart: Ghana

Global Cardiac Surgery

Today, for the first blog of this series, Global Cardiac Surgery is featuring Ghana, a lower-middle-income country in West Africa with a strong history in the realms of cardiothoracic surgery. With a GDP per capita of US$1,513, Ghana falls in the lower-middle-income group (US$996-US$3,895) spanning a population of 28.21